Komori
Takano (7885) · InitiativeAdvanced

Development of Products for the Medical and Welfare Sectors

First written in FY2016. 12 of 20 entries say "Restated". Latest entry: FY2024.

20entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018-Q3AdvancedFY2020 – FY2021AdvancedFY2023-Q3 – FY20242016: 320162017: 320172018: 420182019: 320192020: 220202021: 120212022: 120222023: 220232024: 12024
Same theme, other companies
Market Development through New Technologies, Products and ServicesA theme 58 companies write about · 0 as a headwind · 59 as a tailwind

37 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 58 companies compared. The sentences above are computed from all 58.
Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「The principal theme for the fiscal year was the development of assistive products for people with disabilities. Development was completed and the products were launched.」

    In the medical and welfare sectors, progress was made from completion of development through product launch for assistive products for people with disabilities.
  2. FY2023AdvancedAnnual report

    「The principal theme for the fiscal year was the development of assistive products for people with disabilities and wheelchair cushions. Development of assistive products for people with disabilities is continuing, while development of the wheelchair cushions was completed and the products were launched.」

    In the medical and welfare sectors, progress was made from completion of development through product launch for wheelchair cushions. Development of assistive products for people with disabilities is continuing.
  3. FY2023-Q3AdvancedAnnual report

    「To strengthen these welfare and health sectors, the Group decided to acquire all shares of ユーキ・トレーディング株式会社, which has extensive experience and strong customer relationships in these sectors, with the aim of expanding its sales structure and growing the business.」

    In the welfare and health sectors, progress was made from continuing product development and sales activities to the acquisition of all shares to expand the sales structure. The acquisition was scheduled for 31 March 2023, with an ownership ratio of 100% after the acquisition.
  4. FY2022-Q3RestatedAnnual report

    「In this segment, in response to strong conditions in the semiconductor manufacturing equipment and medical equipment manufacturing industries, we worked to increase production and sales of electromagnetic actuators for these industries.」

    Continued to expand production and sales of electromagnetic actuators, including for the medical equipment manufacturing industry.
  5. FY2021AdvancedAnnual report

    「The principal theme for the fiscal year was the development of mobile powered height-adjustable treatment tables and walkers with speed-control functions. Development of both products was completed, and the products were launched.」

    In the medical and welfare sectors, progress was made from completion of development through product launch for mobile powered height-adjustable treatment tables and walkers with speed-control functions.
  6. FY2020AdvancedAnnual report

    「The principal theme for the fiscal year was the development of products for maintaining a seated position for children. Development was completed, and preparations for the product launch are under way.」

    Completed development of products for maintaining a seated position for children and advanced to the product launch preparation stage.
  7. FY2020-Q3RestatedAnnual report

    「For products intended for medical-related fields, we conducted market launch activities for new products developed in the previous consolidated fiscal year.」

    Continued introducing new products for the medical sector to the market.
  8. FY2020-Q1RestatedAnnual report

    「For products intended for medical-related fields, we conducted market launch activities for new products developed in the previous consolidated fiscal year.」

    Continued market introduction activities for new products for the medical sector.
  9. FY2019AdvancedAnnual report

    「The principal theme for the fiscal year was the development of new examination and treatment tables for medical and clinical settings. Development was completed and the products were launched.」

    For the new examination and treatment tables for medical and clinical settings, progress was made from completion of development through product launch. Meanwhile, activities to develop and introduce new products for the medical sector to the market are continuing.
  10. FY2019-Q3RestatedAnnual report

    「We also developed new products for medical-related fields and conducted market launch activities.」

    Continued activities to develop and introduce products for the medical sector to the market.
  11. FY2019-Q2RestatedAnnual report

    「We also developed new products for medical-related fields and conducted market launch activities.」

    Continued the development and market introduction of products for the medical sector.
  12. FY2019-Q1RestatedAnnual report

    「We also continued expanding the sales organization for products intended for medical-related fields.」

    Continued to expand the sales structure to increase sales of products for the medical sector.
  13. FY2018AdvancedAnnual report

    「The principal theme for the fiscal year was the development of new examination and treatment tables for medical and clinical settings, and development was largely completed.」

    Stated that development of new examination and treatment tables for medical and clinical settings was largely completed.
  14. FY2018-Q3RestatedAnnual report

    「We also worked to expand the sales organization for products intended for medical-related fields.」

    Continued expanding the sales organization for products intended for medical-related fields.
  15. FY2018-Q2RestatedAnnual report

    「Following the previous fiscal year, we pursued active sales proposals for domestic and overseas customers, expanded sales of electromagnetic actuators for the medical sector and semiconductor applications, and developed new core processing technologies.」

    Continued to expand sales of products for the medical sector, along with sales proposals in domestic and overseas markets and the development of core processing technologies.
  16. FY2018-Q1RestatedAnnual report

    「We worked to expand sales of electromagnetic actuators for the medical sector and semiconductor applications, as well as develop new core processing technologies.」

    Continued to expand sales of products for the medical sector, along with sales proposals in overseas and domestic markets and the development of core processing technologies.
  17. FY2017-Q3RestatedAnnual report

    「We also worked to expand the sales structure for products targeting the medical sector.」

    Continued expanding the sales organization for products intended for medical-related fields.
  18. FY2017-Q2RestatedAnnual report

    「We also worked to expand the sales structure for products targeting the medical sector.」

    Continued expanding the sales organization for products intended for medical-related fields.
  19. FY2017-Q1RestatedAnnual report

    「We also worked to expand the sales organization for products intended for medical-related fields.」

    Continued to expand the sales structure, in addition to product development, to grow the business in the medical sector.
  20. FY2016First statedAnnual report

    「We conduct research and development on products and medical equipment that assist with transfers, mobility and seating, enabling older people and people with disabilities to live independently.」

    Positioned the medical sector as a target for new product development and the development of new applications.
Moved together

"Enhancing Competitiveness Through Productivity Improvement, Rationalization and Cost Reduction" moved the same way as this thread, in the same document, in 6 of its 20 moves.

644433★123456
  1. ★This thread
  2. 1Enhancing Competitiveness Through Productivity Improvement, Rationalization and Cost Reduction6×
  3. 2Balancing a Robust Financial Base with Growth Investment4×
  4. 3Exterior Business narrows loss4×
  5. 4Expansion into inspection equipment fields beyond FPDs4×
  6. 5Working Capital Risk from Long Collection Periods for Inspection and Measurement Equipment3×
  7. 6Risk of declines in investment securities prices and valuation losses3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Takano's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.